Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
NCT07362927
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Macular Edema (DME)
Interventions
GENETIC:
LX111 Injection
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators
[object Object]